VivoSeq
Other

Gene Expression

0

Pipeline Programs

2

Active Trials

1

Companies Involved

Gene Expression is an early-stage landscape with 0 programs across 1 company. The most active players are Solvay Pharmaceuticals.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

76/100

Attrition Rate

21/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

24

clinical trials

Completed16 · 67%
Terminated3 · 13%
Recruiting2 · 8%
Withdrawn2 · 8%
Unknown status1 · 4%

Trial Activity

24 trials

Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)